Sal Trading, LLC Novo Nordisk A S Call Options Transaction History

Sal Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $400,136 - $877,976	4,400 Added 115.79%	8,200 $745,000
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $233,969 - $258,975	1,500 Added 65.22%	3,800 $614,000
Q1 2023 May 16, 2023	SELL	$132.34 - $159.14 $661,700 - $795,699	-5,000 Reduced 68.49%	2,300 $366,000
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $748,615 - $987,909	7,300 New	7,300 $987,000
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $619,440 - $730,860	6,000 New	6,000 $669,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Sal Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Sal Trading, LLC with notifications on news.